These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35087132)

  • 1. CD97 is associated with mitogenic pathway activation, metabolic reprogramming, and immune microenvironment changes in glioblastoma.
    Safaee MM; Wang EJ; Jain S; Chen JS; Gill S; Zheng AC; Garcia JH; Beniwal AS; Tran Y; Nguyen AT; Trieu M; Leung K; Wells J; Maclean JM; Wycoff K; Aghi MK
    Sci Rep; 2022 Jan; 12(1):1464. PubMed ID: 35087132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.
    Safaee M; Clark AJ; Oh MC; Ivan ME; Bloch O; Kaur G; Sun MZ; Kim JM; Oh T; Berger MS; Parsa AT
    PLoS One; 2013; 8(4):e62765. PubMed ID: 23658650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD97 Is Decreased in Preeclamptic Placentas and Promotes Human Trophoblast Invasion Through PI3K/Akt/mTOR Signaling Pathway.
    Shen H; Jin M; Gu S; Wu Y; Yang M; Hua X
    Reprod Sci; 2020 Aug; 27(8):1553-1561. PubMed ID: 32430705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway.
    Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS
    J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells.
    Safaee M; Fakurnejad S; Bloch O; Clark AJ; Ivan ME; Sun MZ; Oh T; Phillips JJ; Parsa AT
    PLoS One; 2015; 10(2):e0111532. PubMed ID: 25714433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability.
    Ravn-Boess N; Roy N; Hattori T; Bready D; Donaldson H; Lawson C; Lapierre C; Korman A; Rodrick T; Liu E; Frenster JD; Stephan G; Wilcox J; Corrado AD; Cai J; Ronnen R; Wang S; Haddock S; Sabio Ortiz J; Mishkit O; Khodadadi-Jamayran A; Tsirigos A; Fenyö D; Zagzag D; Drube J; Hoffmann C; Perna F; Jones DR; Possemato R; Koide A; Koide S; Park CY; Placantonakis DG
    Cell Rep; 2023 Nov; 42(11):113374. PubMed ID: 37938973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
    Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB
    Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.
    Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G
    Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway.
    Li C; Liu DR; Li GG; Wang HH; Li XW; Zhang W; Wu YL; Chen L
    World J Gastroenterol; 2015 May; 21(20):6215-28. PubMed ID: 26034356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M; Lule S; Demir O; Kurnaz IA; Vural I
    Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma.
    Lailler C; Louandre C; Morisse MC; Lhossein T; Godin C; Lottin M; Constans JM; Chauffert B; Galmiche A; Saidak Z
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
    Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
    Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma.
    Li Q; Liu X; Mao J; Liu S; Hou B; Li K; Fang D
    Biochem Biophys Res Commun; 2023 Oct; 676():149-157. PubMed ID: 37517217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
    Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
    Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma.
    Nakazawa T; Morimoto T; Maeoka R; Yamada K; Matsuda R; Nakamura M; Nishimura F; Yamada S; Park YS; Tsujimura T; Nakagawa I
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion.
    Wang Y; Sakaguchi M; Sabit H; Tamai S; Ichinose T; Tanaka S; Kinoshita M; Uchida Y; Ohtsuki S; Nakada M
    J Neurosurg; 2023 Mar; 138(3):639-648. PubMed ID: 35932265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.